Position in SNN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$212,226
+$96,473 QoQ
Shares Held
6,678
+89.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MAI Capital Management holds $114,360,678 across 14 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
437,641 | $39,711,543 | |
| 2 | SYK |
Stryker Corp
|
114,533 | $36,059,569 | |
| 3 | BSX |
Boston Scientific Corp
|
519,011 | $22,151,389 | |
| 4 | MDT |
Medtronic plc
|
128,741 | $10,071,407 | |
| 5 | EW |
Edwards Lifesciences Corp
|
26,116 | $2,362,452 | |
| 6 | STE |
STERIS plc
|
4,786 | $1,007,787 | |
| 7 | PODD |
Insulet Corp
|
5,524 | $841,028 | |
| 8 | DXCM |
Dexcom Inc
|
9,049 | $609,450 |
All Filings in SNN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,226 | 6,678 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $115,753 | 3,528 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $128,031 | 3,528 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $133,883 | 4,371 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $100,004 | 3,525 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $89,127 | 3,626 | Shares | Sole | 2025-02-14 | |
| 2021-03-31 | $596,091 | 15,728 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $655,954 | 15,555 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $612,657 | 15,669 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $602,105 | 15,795 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $531,198 | 14,809 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||